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Both targeting of the mitochondrial
electron transport chain and the phar-
macological scavenging of mitochon-
drial superoxide prevent metastatic
dissemination from primary orthotopic
tumors in mice (Porporato et al.,
2014). Mitochondrial-generated oxida-
tive stress can also be attenuated with
clinically relevant health benefits by
increasing the levels of mitochondrial
antioxidant enzymes or by ectopically
expressing antioxidant enzymes within
the mitochondria. For instance, overex-
pression of mitochondrial-localized
catalase in vivo increases lifespan, and
transgenic expression of mitochondrial
catalase in the MMTV-PyMT mammary
cancer model reduces ROS-driven pri-
mary tumor invasiveness and markedly
suppresses lung metastases (Goh
et al., 2011; Schriner et al., 2005).
Therefore, strategies that effectively
eliminate ROS specifically within the
mitochondrial compartment by mito-
chondrial-specific antioxidant adminis-958 Cell Metabolism 22, December 1, 2015 ªtration might still represent a therapeu-
tic approach for metastatic cancer.
Despite intensive research, current
antioxidant strategies are not clinically
effective, suggesting that our under-
standing of this field is limited and the
exact nature of the impact of oxidative
stress on cancer metastasis requires
further investigation. The role of ROS
and antioxidants depending on their
origin in cancer progression and metas-
tasis needs to be fully characterized in
future studies to identify new therapeutic
targets.REFERENCES
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In adipose tissue, there is a delicate balance between storing and expending energy. In this issue, Shinoda
et al. (2015) use phosphoproteomics to identify casein kinase 2 (CK2) as a suppressor of brown adipocyte
formation, providing insights into how adipose tissue regulates its composition of white versus brown
adipocytes.On the one hand, it is well known that pro-
longed exposure to cold will induce
‘‘browning,’’ an increase in the number
of beige adipocytes (also known as brite;
a type of brown adipocyte interspersed
among white adipocytes in predomi-
nantly white adipose depots), while on
the other hand high-fat diet feeding or
exposure to thermoneutrality (a tempera-
ture of about 28C–30C, at which micedo not need to activate brown fat for
heat production) will have the opposite
effect, with less browning and more of a
homogenous white phenotype of adipose
depots (Cinti, 2005). Thus, the adipose
tissue is a dynamic tissue that responds
and adapts to physiological stimuli such
as nutritional status and changes in
ambient temperature. Using in vivo ge-
netic lineage tracing techniques, Leeet al. (2012) identified a PDGFRa+,
CD34+, and Sca1+ precursor cell with
the capacity to proliferate and differen-
tiate into both brown and white adipo-
cytes. Such bipotent precursors devel-
oped into brown adipocytes when mice
were treated with a b3-agonist (mimicking
cold exposure) and into white adipocytes
when mice were high-fat fed. This impor-
tant finding helps explain the dynamics of
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Previewsadipose tissue and predicts the existence
of a switch that under cold exposure ac-
tivates a brown fat gene program and,
during high-fat feeding, suppresses this
program and at the same time activates
white adipocyte formation. A key compo-
nent of this switch is the PRDM16-C/
EBP-b transcriptional complex—when
these factors are expressed in native fi-
broblasts they induce a fully functional
brown fat program (Kajimura et al.,
2009). Further details on how this regula-
tion is executed both in terms
of activation and suppression of the
different gene programs involved are
starting to accumulate, and most factors
reported are activators of brown fat for-
mation/function. This complex regulation
involves several factors/processes, such
as chromatin remodeling mediated by
EHMT1 (Ohno et al., 2013), transcrip-
tional activation by Ebf2 and Pparg (Raja-
kumari et al., 2013), and the signal-
sensing scaffold JMJD1A (Abe et al.,
2015). In this issue of Cell Metabolism,
Shinoda et al. (2015) use a phosphopro-
teomics approach and find that the ca-
seine kinase CK2 acts as a repressor of
brown fat formation.
Shinoda et al. (2015) set out to study
how white, beige, and classical brown
adipocytes respond to norepinephrine
administration, emphasizing activation or
suppression of kinases. For this purpose
a set of cell lines and primary cells repre-
senting the three different types of adipo-
cytes were treated with norepinephrine
and subsequently analyzed by LC-MS/
MS to compare phosphorylation profiles.
This phosphoproteomics approach re-
vealed that five kinases differed between
brown and white adipocytes. Further
analysis showed that, after norepineph-
rine administration, one of these kinases,
caseine kinase 2 (CK2), was more active
in primary white adipocytes compared to
both brown and beige adipocytes. More-
over, CK2 activity was induced in the
inguinal WAT depot after high-fat feeding.
Interestingly, this increase in CK2 activity
was selective for WAT since no change
in CK2 activity was found in BAT. WhenCK2was suppressed in white adipocytes,
either by RNAi or a pharmacological
approach using the CK2 inhibitor CX-
4945, there was a robust induction of
Ucp1 and several other brown selective
genes such as Cidea, Cited1, and Elov3.
This is an important finding since it reveals
that active suppression of brown fat for-
mation in WAT is an integral part of how
adipose tissue regulates its cellular
composition of brown versus white adipo-
cytes. The authors then demonstrated
that phosphorylation of class I HDACs,
HDAC1 and HDAC2, was strikingly
reduced by CK2 inhibition in white adipo-
cytes, consistent with increased brown-
ing, since inhibition of class I HDACs has
been linked to increased expression of
PGC1a (Galmozzi et al., 2013).
With the addition of CK2 to the family of
genes regulating the cellular composition
of adipose tissue depots, the field has
taken yet another step toward a compre-
hensive map of the molecular events
underlying how this tissue dynamically re-
sponds to changes in metabolic status,
ambient temperature, and other chal-
lenges to metabolic homeostasis. We
can now start to dissect, at the molecular
level, how the transcriptional machinery
including chromatin remodeling responds
to such changes. What are the crucial
steps in responding to nutritional cues
versus defense of normal body tempera-
ture during cold exposure? Are these sig-
nals transmitted via direct innervation
and/or through soluble factors like hor-
mones and cytokines? A lot of attention
has been focused on adrenergic PKA-
mediated effects on adipose tissue
composition, as shown by Shinoda et al.
(2015) for the regulation of CK2. How
important is this type of regulation in
comparison to that of other potent regula-
tors of adipose tissue function such as se-
rotonin (Oh et al., 2015) and adenosine
(Gnad et al., 2014)?
These findings that demonstrate a role
of CK2 as a repressor of browning in
adipose tissue are important not only
from a biological science perspective,
but also from a therapeutic angle, sinceCell Metabolism 22,they provide a new distinct activity and
the possibility of identifying new gene
products that take part in regulating CK2
activity that can be targeted and tested
for therapeutic purposes. The ultimate
aim is to provide a safe and efficient way
of activating BAT in humans so that
the beneficial effects of having ample
amounts of brown fat can be made avail-
able to all that suffer from obesity and
obesity-linked maladies such as type 2
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